Traws Pharma Inc. held its annual meeting of stockholders on November 21, 2025. At the meeting, all nominated directors were elected to the board. Stockholders also approved an amendment and restatement of the company's incentive compensation plan, which increases the number of shares reserved for issuance and extends the plan's term.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Traws Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-116962), on November 28, 2025, and is solely responsible for the information contained therein.